We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+2.43%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$8.8B
AUM Growth
+$346M
Cap. Flow
+$350M
Cap. Flow %
3.97%
Top 10 Hldgs %
18.46%
Holding
1,111
New
53
Increased
455
Reduced
293
Closed
123

Top Buys

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$77.4M
2
T icon
AT&T
T
+$35.6M
3
DB icon
Deutsche Bank
DB
+$33.1M
4
SPGI icon
S&P Global
SPGI
+$25M
5
TXN icon
Texas Instruments
TXN
+$24M

Top Sells

Rank Stock Value
1
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$37.1M
2
HCA icon
HCA Healthcare
HCA
+$24.6M
3
AWK icon
American Water Works
AWK
+$23.9M
4
UBS icon
UBS Group
UBS
+$18.4M
5
MFC icon
Manulife Financial
MFC
+$15.5M

Sector Composition

Rank Sector Weight
1 Healthcare 18.43%
2 Financials 14.33%
3 Communication Services 12.73%
4 Technology 11.92%
5 Consumer Staples 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVNC
1051
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-13,600
Closed -$239K
LUMO
1052
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-1,378
Closed -$213K
TUP
1053
DELISTED
Tupperware Brands Corporation
TUP
– –
-50,606
Closed -$2.9M
TRVN
1054
DELISTED
Trevena, Inc.
TRVN
– –
-38
Closed -$196K
IMGN
1055
DELISTED
Immunogen Inc
IMGN
– –
-37,700
Closed -$311K
ARAV
1056
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-2,250
Closed -$106K
INFI
1057
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-21,500
Closed -$111K
SPPI
1058
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-28,500
Closed -$179K
BLCM
1059
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-1,400
Closed -$123K
CNCE
1060
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-9,600
Closed -$127K
OTIC
1061
DELISTED
Otonomy, Inc.
OTIC
– –
-15,100
Closed -$223K
AGTC
1062
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-8,200
Closed -$113K
CCXI
1063
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-25,000
Closed -$58K
SRRA
1064
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-350
Closed -$97K
HMHC
1065
DELISTED
Houghton Mifflin Harcourt Company
HMHC
– –
-23,580
Closed -$458K
ARNA
1066
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-10,100
Closed -$193K
ADMS
1067
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-10,800
Closed -$152K
FLXN
1068
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-10,500
Closed -$94K
TLGT
1069
DELISTED
Teligent, Inc
TLGT
– –
-2,200
Closed -$103K
CHMA
1070
DELISTED
Chiasma, Inc. Common Stock
CHMA
– –
-11,500
Closed -$99K
NEOS
1071
DELISTED
Neos Therapeutics, Inc
NEOS
– –
-7,500
Closed -$77K
IMMU
1072
DELISTED
Immunomedics Inc
IMMU
– –
-40,000
Closed -$100K
WUBA
1073
DELISTED
58.com Inc
WUBA
– –
-1,600
Closed -$88K
LM
1074
DELISTED
Legg Mason, Inc.
LM
– –
-3,206
Closed -$111K
TTPH
1075
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-950
Closed -$83K
41 42
43
44 45

Similar funds

Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

DekaBank Deutsche Girozentrale's Q2 2016 Portfolio in Review

As of Q2 2016, DekaBank Deutsche Girozentrale held 1,111 positions worth $8.8B, up 4.1% from $8.45B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

DekaBank Deutsche Girozentrale deployed $350M of net new capital in Q2 2016, opening 53 new positions and adding to 455 existing holdings. Its largest new stake was S&P Global: 232,858 shares worth $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was HCA Healthcare, an estimated $24.6M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q2 2016 buy was S&P Global: 232,858 shares worth $24.7M.
  • DekaBank Deutsche Girozentrale added most to Charter Communications in Q2 2016, an estimated $77.4M increase.
  • DekaBank Deutsche Girozentrale's biggest Q2 2016 reduction was HCA Healthcare, cutting an estimated $24.6M.
  • DekaBank Deutsche Girozentrale fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $37.1M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 18% of its $8.8B portfolio in Q2 2016.
  • DekaBank Deutsche Girozentrale opened 53 new positions and closed 123 in Q2 2016.
  • DekaBank Deutsche Girozentrale's portfolio value rose 4.1% quarter-over-quarter to $8.8B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.